INNOVYZE LLC – Trademark Portfolio
Entity Type: 16
INNOVYZE LLC holds 24 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 19 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 10 trademarks are registered. Notable registered marks include IWLIVE, H2OCALC, ICMLIVE, INFO360, and NETVIEW. The owner is based in PORTLAND, OR.
6720 SW MACADAM AVENUE, SUITE 200
PORTLAND, OR 97219
Showing of trademarks Trademarks
Trademark Classifications
INNOVYZE LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does INNOVYZE LLC have?
INNOVYZE LLC has 24 U.S. trademarks filed with the USPTO. Of these, 10 registered, 1 abandoned, 13 cancelled.
What trademark classes does INNOVYZE LLC file in?
INNOVYZE LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 41 (Education & Entertainment). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are INNOVYZE LLC's most well-known trademarks?
INNOVYZE LLC's registered trademark portfolio includes well-known marks such as IWLIVE, H2OCALC, ICMLIVE, INFO360, and NETVIEW. These are among 10 currently registered trademarks in the portfolio.
What is INNOVYZE LLC's trademark registration success rate?
INNOVYZE LLC has a 42% trademark registration rate, with 10 out of 24 resolved applications resulting in successful registration. Currently, 0 applications are pending review.